| Pharmacy Counter Llc | |
| 1515 S Byrne Rd, Ste 119, Toledo, Ohio 43614 | |
| (419) 382-3475 |
| Name | Pharmacy Counter Llc |
|---|---|
| Organization Name | Pharmacy Counter Llc |
| Location | 1515 S Byrne Rd, Ste 119, Toledo, Ohio 43614 |
| Type | Community/Retail Pharmacy |
| Phone | (419) 382-3475 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A new strain of the coronavirus has been found in more than one-third of COVID-19 cases in Los Angeles and may be contributing to the acceleration of the recent surge of cases across Southern California, according to new research from Cedars-Sinai.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for investigational compound dapagliflozin for the treatment of type 2 diabetes in adults.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced it has received FDA clearance for a new Clostridium difficile assay, ImmunoCard C. difficile GDH.
Sharing of electronic health information across every major emergency department in the Memphis, Tenn., area resulted in reduced hospital admissions, reduced radiology tests and an annual cost savings of nearly $2 million, according to a Vanderbilt study released today by the Journal of the American Medical Informatics Association.
Biologists at UC San Diego have found that a method they developed to identify and characterize new antibiotics can be employed to screen natural products quickly for compounds capable of controlling antibiotic resistant bacteria.
› Verified 8 days ago
| NPI Number | 1194882084 |
| Organization Name | COLONY PHARMACY, INC |
| Doing Business As | THE PHARMACY COUNTER |
| Type | Community/Retail Pharmacy |
| Address | 1515 S Byrne Rd, Toledo, OH 43614 |
| Phone Number | 419-382-3475 |
News Archive
A new strain of the coronavirus has been found in more than one-third of COVID-19 cases in Los Angeles and may be contributing to the acceleration of the recent surge of cases across Southern California, according to new research from Cedars-Sinai.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for investigational compound dapagliflozin for the treatment of type 2 diabetes in adults.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced it has received FDA clearance for a new Clostridium difficile assay, ImmunoCard C. difficile GDH.
Sharing of electronic health information across every major emergency department in the Memphis, Tenn., area resulted in reduced hospital admissions, reduced radiology tests and an annual cost savings of nearly $2 million, according to a Vanderbilt study released today by the Journal of the American Medical Informatics Association.
Biologists at UC San Diego have found that a method they developed to identify and characterize new antibiotics can be employed to screen natural products quickly for compounds capable of controlling antibiotic resistant bacteria.
› Verified 8 days ago
| NPI Number | 1205166154 |
| Organization Name | PHARMACY COUNTER, LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1515 S Byrne Rd, Suite 119, Toledo, OH 43614 |
| Phone Number | 419-382-3475 |
News Archive
A new strain of the coronavirus has been found in more than one-third of COVID-19 cases in Los Angeles and may be contributing to the acceleration of the recent surge of cases across Southern California, according to new research from Cedars-Sinai.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for investigational compound dapagliflozin for the treatment of type 2 diabetes in adults.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced it has received FDA clearance for a new Clostridium difficile assay, ImmunoCard C. difficile GDH.
Sharing of electronic health information across every major emergency department in the Memphis, Tenn., area resulted in reduced hospital admissions, reduced radiology tests and an annual cost savings of nearly $2 million, according to a Vanderbilt study released today by the Journal of the American Medical Informatics Association.
Biologists at UC San Diego have found that a method they developed to identify and characterize new antibiotics can be employed to screen natural products quickly for compounds capable of controlling antibiotic resistant bacteria.
› Verified 8 days ago
News Archive
A new strain of the coronavirus has been found in more than one-third of COVID-19 cases in Los Angeles and may be contributing to the acceleration of the recent surge of cases across Southern California, according to new research from Cedars-Sinai.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for investigational compound dapagliflozin for the treatment of type 2 diabetes in adults.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced it has received FDA clearance for a new Clostridium difficile assay, ImmunoCard C. difficile GDH.
Sharing of electronic health information across every major emergency department in the Memphis, Tenn., area resulted in reduced hospital admissions, reduced radiology tests and an annual cost savings of nearly $2 million, according to a Vanderbilt study released today by the Journal of the American Medical Informatics Association.
Biologists at UC San Diego have found that a method they developed to identify and characterize new antibiotics can be employed to screen natural products quickly for compounds capable of controlling antibiotic resistant bacteria.
› Verified 8 days ago
Health Care Solutions Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2950 Centennial Rd, Toledo, Ohio 43617 Phone: (419) 842-8040 | |
Rite Aid Pharmacy #07817 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7504 W Central Ave, Toledo, Ohio 43617 Phone: (419) 841-8525 | |
Rite Aid Pharmacy #06683 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3911 Secor Rd, Toledo, Ohio 43623 Phone: (419) 472-8027 | |
Rite Aid Pharmacy #01217 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5765 Secor Rd, Toledo, Ohio 43623 Phone: (419) 473-2451 | |
Rite Aid Pharmacy #02340 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2434 W Laskey Rd, Toledo, Ohio 43613 Phone: (419) 473-1221 |